Jacob Liu, MD
Family Medicine · Columbus, OHNPI 1699031427
Payments from drug & device makers
Across 143 payments — averaging $13.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$329
- AstraZeneca$185
- Merck$171
- Avanir Pharmaceuticals, Inc.$149
- Novo Nordisk$144
- Johnson & Johnson$142
- plus $817 from 14 others
What the payments were for
- Food & beverage$1,86396%
- Education$744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $329 |
| AstraZeneca | 11 | $185 |
| Merck | 20 | $171 |
| Avanir Pharmaceuticals, Inc. | 3 | $149 |
| Novo Nordisk | 21 | $144 |
| Johnson & Johnson | 8 | $142 |
| AbbVie(2 entities) | 15 | $134 |
| Amgen | 9 | $124 |
| Lilly USA, LLC | 7 | $94 |
| Astellas Pharma US Inc | 6 | $87 |
| Exact Sciences | 5 | $81 |
| Boehringer Ingelheim | 4 | $62 |
| Pfizer | 2 | $57 |
| GSK | 2 | $38 |
| Novartis | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $27 |
| Medtronic | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUEDEXTA$125
- TRINTELLIX$114
How this compares
$1,938 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 67 | $76,398 |
| EliquisApixaban | 51 | $50,350 |
| XareltoRivaroxaban | 42 | $47,172 |
| TrulicityDulaglutide | 32 | $38,315 |
| RybelsusSemaglutide | 17 | $31,631 |
| JanuviaSitagliptin Phosphate | 23 | $30,434 |
| JardianceEmpagliflozin | 11 | $14,771 |
| TrintellixVortioxetine Hydrobromide | 12 | $12,486 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,925 |
| Repatha SureclickEvolocumab | 12 | $6,337 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 26 | $5,921 |
| Rosuvastatin Calcium | 297 | $5,446 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 13 | $4,320 |
| Atorvastatin Calcium | 324 | $2,805 |
| Vilazodone Hcl | 12 | $2,745 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $144 | $108,02884 claims |
| PfizerEliquis, Abrysvo, Paxlovid | $57 | $56,09976 claims |
| Johnson & JohnsonXarelto | $142 | $47,17242 claims |
| Lilly USA, LLCTrulicity | $94 | $38,31532 claims |
| MerckJanuvia | $171 | $30,43423 claims |
| GSKTrelegy Ellipta, Shingrix | $38 | $17,84643 claims |
| Boehringer IngelheimJardiance | $62 | $14,77111 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $329 | $12,48612 claims |
| AbbVieSynthroid | $134 | $94735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Columbus
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
- Robert FloreaColumbus$955K
- Bryan FeldmanColumbus$404K
- Scott MerrymanColumbus$89K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.